Litwin T - Search Results

1

Families with Wilson's disease in subsequent generations: clinical and genetic analysis.

Dzieżyc K, Litwin T, Chabik G, Gramza K, Członkowska A. Dzieżyc K, et al. Among authors: litwin t. Mov Disord. 2014 Dec;29(14):1828-32. doi: 10.1002/mds.26057. Epub 2014 Oct 18. Mov Disord. 2014. PMID: 25327413

2

Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease.

Kurkowska-Jastrzebska I, Litwin T, Joniec I, Ciesielska A, Przybyłkowski A, Członkowski A, Członkowska A. Kurkowska-Jastrzebska I, et al. Among authors: litwin t. Int Immunopharmacol. 2004 Oct;4(10-11):1307-18. doi: 10.1016/j.intimp.2004.05.006. Int Immunopharmacol. 2004. PMID: 15313429

3

Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not influence the proportion of patients treated.

Kobayashi A, Skowronska M, Litwin T, Czlonkowska A. Kobayashi A, et al. Among authors: litwin t. Emerg Med J. 2007 Feb;24(2):96-9. doi: 10.1136/emj.2006.040204. Emerg Med J. 2007. PMID: 17251612 Free PMC article.

4

Neurological presentation of Wilson's disease in a patient after liver transplantation.

Litwin T, Gromadzka G, Członkowska A. Litwin T, et al. Mov Disord. 2008 Apr 15;23(5):743-6. doi: 10.1002/mds.21913. Mov Disord. 2008. PMID: 18181205

5

Thrombolysis in acute ischaemic stroke within 3 hours of symptom onset: a report of the first 100 cases.

Litwin T, Kobayashi A, Skowrońska M, Członkowska A. Litwin T, et al. Neurol Neurochir Pol. 2008 Jan-Feb;42(1):1-5. Neurol Neurochir Pol. 2008. PMID: 18365956 Clinical Trial.

6

Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry.

Kobayashi A, Czlonkowska A, Ahmed N, Romanowicz S, Glonek M, Nyka WM, Opala G, Wahlgren N; SITS Poland Collaborative Group. Kobayashi A, et al. Acta Neurol Scand. 2010 Oct;122(4):229-36. doi: 10.1111/j.1600-0404.2009.01294.x. Epub 2009 Nov 16. Acta Neurol Scand. 2010. PMID: 19919643

7

Wilson's disease: does iron metabolism impact phenotypic presentation?

Litwin T, Gromadzka G, Członkowska A. Litwin T, et al. Liver Int. 2012 May;32(5):869-70; author reply 870. doi: 10.1111/j.1478-3231.2012.02756.x. Epub 2012 Jan 31. Liver Int. 2012. PMID: 22292432 No abstract available.

8

Influence of BDNF polymorphisms on Wilson's disease susceptibility and clinical course.

Mirowska-Guzel D, Litwin T, Gromadzka G, Czlonkowski A, Czlonkowska A. Mirowska-Guzel D, et al. Among authors: litwin t. Metab Brain Dis. 2013 Sep;28(3):447-53. doi: 10.1007/s11011-013-9399-x. Epub 2013 Mar 22. Metab Brain Dis. 2013. PMID: 23519890 Free PMC article.

9

Positivity of serum "classical" onconeural antibodies in a series of 2063 consecutive patients with suspicion of paraneoplastic neurological syndrome.

Gromadzka G, Karlińska AG, Łysiak Z, Błażejewska-Hyżorek B, Litwin T, Członkowska A. Gromadzka G, et al. Among authors: litwin t. J Neuroimmunol. 2013 Jun 15;259(1-2):75-80. doi: 10.1016/j.jneuroim.2013.04.007. Epub 2013 Apr 30. J Neuroimmunol. 2013. PMID: 23642452

10

[Wilson disease - factors affecting clinical presentation].

Litwin T, Członkowska A. Litwin T, et al. Neurol Neurochir Pol. 2013 Mar-Apr;47(2):161-9. doi: 10.5114/ninp.2013.34397. Neurol Neurochir Pol. 2013. PMID: 23650006 Review. Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters